Patent 7098012 was granted and assigned to McGill on August, 2006 by the United States Patent and Trademark Office.
The present invention relates to a DNA demethylase enzyme having about 40 KDa, and wherein said DNA demethylase enzyme is overexpressed in cancer cells and not in normal cells. The present invention also relates to the therapeutic and diagnostic uses of the DNA demethylase.